Zobrazeno 1 - 4
of 4
pro vyhledávání: '"A. Dharshini Aishwarya"'
Autor:
V. Alagarsamy, V. Raja Solomon, M. T. Sulthana, P. Shyam Sundar, A. Dharshini Aishwarya, B. Narendhar
Publikováno v:
Letters in Drug Design & Discovery. 20:1380-1392
Background: Severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro) is an important target for drug development amidst whole variants of coronaviruses, a vital protein for the replication cycle of virus. Objective: The main ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67210ad70841f848d3626912383f6c2f
https://doi.org/10.2174/1570180819666220929151127
https://doi.org/10.2174/1570180819666220929151127
Autor:
V. Alagarsamy, P. Shyam Sundar, B. Narendhar, M. T. Sulthana, Vishaka S. Kulkarni, A. Dharshini Aishwarya, V. Raja Solomon, S. Murugesan, S. Jubie, K. Rohitha, Sangeetha Dhanwar
Publikováno v:
Medicinal Chemistry. 19
Background: A limited number of small molecules against SARS-CoV-2 has been discovered since the epidemic commenced in November 2019. The conventional medicinal chemistry approach demands more than a decade of the year of laborious research and devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a6edd6a2cc9e4ef9932701e5b071fec
https://doi.org/10.2174/1573406419666230413112802
https://doi.org/10.2174/1573406419666230413112802
Autor:
Alagarsamy, V., Shyam Sundar, P., Raja Solomon, V., Narendhar, B., Sulthana, M. T., Rohitha, Kotha, Dhanwar, Sangeeta, Dharshini Aishwarya, A., Murugesan, S.
Publikováno v:
Journal of Biomolecular Structure and Dynamics; December 2023, Vol. 41 Issue: 20 p10678-10689, 12p
Autor:
V. Alagarsamy, V. Raja Solomon, P. Shyam Sundar, Vishaka S. Kulkarni, M.T. Sulthana, A. Dharshini Aishwarya, B. Narendhar, S. Murugesan
Publikováno v:
Current computer-aided drug design.
Background: To date, very few small drug molecules are used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has been discovered since the epidemic commenced in November 2019. SARS-CoV-2 RdRp and spike protein are essential targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480ab52a36e4b4f0e72664266d93f3e7
https://pubmed.ncbi.nlm.nih.gov/36424783
https://pubmed.ncbi.nlm.nih.gov/36424783